GUANZE MEDICAL (02427) announced that the offer price has been fixed at HK$0.53 per share of the offer. After deducting entry fees and commissions and estimated expenses payable by the company for the global offering, the company will receive estimated net proceeds from the global offering of approximately HK$73.3 million. There are 5,000 shares per board lot and the shares are expected to trade on the Hong Kong Stock Exchange at 9:00 am on December 29, 2022 (Thursday).
The Hong Kong Offering Shares initially offered in the Hong Kong Public Offering were moderately oversubscribed. The company has received a total of 4,492 valid applications to subscribe for a total of 274 million Hong Kong Offering Shares under the Hong Kong Public Offering, which is approximately 14.23 times the total number of 19.285 million Hong Kong Offering Shares initially available for subscription as part of the Hong Kong public offering.
Massive information, accurate interpretation, all in the Sina Finance APP
Responsible editor: Lu Yujun
